Prostate Cancer
Magnetic Resonance Perfusion Imaging of Prostate.
November 28, 2023
Combiner and HyperCombiner networks: Rules to combine multimodality MR images for prostate cancer localisation.
November 28, 2023
Targeting the αVβ3/ngr2 Pathway in Neuroendocrine Prostate Cancer
November 27, 2023
Salvage Radical Prostatectomy for Recurrent Prostate Cancer: A Systematic Review (French ccAFU).
November 27, 2023
Prostate-Specific Membrane Antigen (PSMA) Expression Predicts Need for Early Treatment in Prostate Cancer Patients Managed with Active Surveillance.
November 27, 2023
Regulation of EZH2 Expression by INPP4B in Normal Prostate and Primary Prostate Cancer.
November 27, 2023
ZNF397 Loss Triggers TET2-driven Epigenetic Rewiring, Lineage Plasticity, and AR-targeted Therapy Resistance in AR-dependent Cancers.
November 27, 2023
Comparing Active Surveillance and Watchful Waiting With Radical Treatment Using Machine Learning Models Among Patients With Prostate Cancer.
November 24, 2023
MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression.
November 24, 2023
Benefit and harm of lymphadenectomy in intermediate risk prostate cancer: comparison of five nomograms.
November 24, 2023
Men's Acceptance of Screening for Prostate Cancer with Prostate-specific Antigen, Magnetic Resonance Imaging, and Prostate Biopsy.
November 24, 2023
Uncovering prostate cancer aggressiveness signal in T2-weighted MRI through a three-reference tissues normalization technique.
November 23, 2023
A common germline variant in CYP11B1 is associated with adverse clinical outcome of treatment with abiraterone or enzalutamide.
November 23, 2023